These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29426974)

  • 1. Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome.
    Kamei K; Ogura M; Sato M; Ito S; Ishikura K
    Pediatr Nephrol; 2018 Jun; 33(6):1013-1018. PubMed ID: 29426974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.
    Bonanni A; Calatroni M; D'Alessandro M; Signa S; Bertelli E; Cioni M; Di Marco E; Biassoni R; Caridi G; Ingrasciotta G; Bertelli R; Di Donato A; Bruschi M; Canepa A; Piaggio G; Ravani P; Ghiggeri GM
    Br J Clin Pharmacol; 2018 Jun; 84(6):1238-1249. PubMed ID: 29436729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome.
    Fujinaga S; Nishino T; Endo S; Umeda C; Watanabe Y; Nakagawa M
    Pediatr Nephrol; 2020 Oct; 35(10):2003-2008. PubMed ID: 32556955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
    Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K;
    Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
    Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
    Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
    Miyabe Y; Takei T; Iwabuchi Y; Moriyama T; Nitta K
    Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial.
    Ravani P; Colucci M; Bruschi M; Vivarelli M; Cioni M; DiDonato A; Cravedi P; Lugani F; Antonini F; Prunotto M; Emma F; Angeletti A; Ghiggeri GM
    J Am Soc Nephrol; 2021 Oct; 32(10):2652-2663. PubMed ID: 34544820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.
    Sato M; Kamei K; Ogura M; Ishikura K; Ito S
    Clin Exp Nephrol; 2018 Feb; 22(1):110-116. PubMed ID: 28434126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S; Hirano D; Mizutani A; Sakuraya K; Yamada A; Sakurai S; Shimizu T
    Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
    McAtee CL; Lubega J; Underbrink K; Curry K; Msaouel P; Barrow M; Muscal E; Lotze T; Srivaths P; Forbes LR; Allen C; Bernhardt MB
    JAMA Netw Open; 2021 Feb; 4(2):e2036321. PubMed ID: 33533931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome.
    Kobayashi M; Kageyama Y; Ando T; Sakamoto J; Kimura S
    Clin Exp Nephrol; 2021 Aug; 25(8):854-864. PubMed ID: 33796934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
    Delbet JD; Leclerc G; Ulinski T
    Pediatr Nephrol; 2019 Mar; 34(3):529-532. PubMed ID: 30542932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review.
    Jellouli M; Charfi R; Maalej B; Mahfoud A; Trabelsi S; Gargah T
    J Pediatr; 2018 Jun; 197():191-197.e1. PubMed ID: 29680473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.
    Inoki Y; Kamei K; Nishi K; Sato M; Ogura M; Ishiguro A
    Pediatr Nephrol; 2022 May; 37(5):1057-1066. PubMed ID: 34606002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
    Vivarelli M; Colucci M; Bonanni A; Verzani M; Serafinelli J; Emma F; Ghiggeri G
    Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Pregnancies in a Patient with Childhood-onset Steroid-dependent Nephrotic Syndrome during Rituximab Maintenance Therapy.
    Nara M; Kaga H; Saito M; Abe F; Saito A; Imaizumi C; Komatsuda A; Wakui H; Takahashi N
    Intern Med; 2021 Sep; 60(18):2985-2989. PubMed ID: 33776000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.
    Hogan J; Dossier C; Kwon T; Macher MA; Maisin A; Couderc A; Niel O; Baudouin V; Deschênes G
    Pediatr Nephrol; 2019 Feb; 34(2):253-259. PubMed ID: 30109447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for childhood refractory nephrotic syndrome.
    Iijima K
    Pediatr Int; 2011 Oct; 53(5):617-621. PubMed ID: 21771179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.
    Ravani P; Rossi R; Bonanni A; Quinn RR; Sica F; Bodria M; Pasini A; Montini G; Edefonti A; Belingheri M; De Giovanni D; Barbano G; Degl'Innocenti L; Scolari F; Murer L; Reiser J; Fornoni A; Ghiggeri GM
    J Am Soc Nephrol; 2015 Sep; 26(9):2259-66. PubMed ID: 25592855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.